EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PIP5K isoforms and phosphoinositide molecular species in EGF-stimulated PIP3 synthesis: A multi-method approach using enzyme genetic suppression and chemical inhibition in MCF10A cells

Iosif Alexandrou iD, Vikki Flemington, Martin E Swarbrick iD, Sabina Cosulich, Phillip T Hawkins, Len R Stephens

PLOS One · 05.11.2026 · 21 (11) · e0362260

DOI: 10.1371/journal.pone.0362260 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 05.11.2026. Verfasst von Iosif Alexandrou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Babraham Institute, Cambridge, United Kingdom. Hauptthemen laut MEDLINE: Epidermal Growth Factor, Phosphotransferases (Alcohol Group Acceptor), Phosphatidylinositols, Phosphatidylinositol Phosphates. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The membrane phospholipid PI(4,5)P 2 has structural functions and is a substrate for PLC and PI3K enzymes to generate Ins(1,4,5)P 3 , DAG and PI(3,4,5)P 3 signals. PIP5Ks, that 5-phosphorylate PI4P, are the major source of PI(4,5)P 2 in mammalian cells. Current thinking suggests distinct pools of PI(4,5)P 2 may be differentially generated by PIP5Kα, β and γ isoforms and involved in different physiological functions. Phosphoinositides are comprised of families of acyl-chain variants but are uniquely enriched in C38:4 species. There is evidence that PIP5Ks are selective for certain acyl chain species of PI(4)P. We aimed to understand how inhibition of PIP5Ks impacts PIP 3 production and whether they differentially support synthesis of a pool of PI(4,5)P 2 , that may be marked by a distinct profile of molecular species variants, which supply class I PI3Ks in a non-transformed human cell line (MCF10A cells). Using a combination of siRNA, Cas9/CRISPR-mediated gene knockout (k/o), recently derived selective, small-molecule inhibitors of PIP5Ks and mass-spectrometry-based lipidomic techniques, we attempted to address these questions. We found that MCF10A cells only express PIP5Kα and γ and that neither siRNA-mediated reduction nor k/o of either protein changed the levels or acyl chain profiles of any of the phosphoinositides in Epidermal Growth Factor- (EGF) stimulated MCF10A cells. We found that selective PIP5K inhibition reduced levels of PIP 2 and EGF-stimulated PIP 3 and increased levels of PIP, however, the acyl-chain-profiles of none of these lipids were significantly altered in MCF10A cells. We found EGF-stimulated Akt, EGF Receptor (EGFR) and MAPK phosphorylation were also reduced by PIP5K inhibitors in this cell line. To deconvolute these results, we tested the impact of a selective PI3Kα inhibitor (A66) and found it inhibited PIP 3 accumulation and Akt phosphorylation and reduced MAPK phosphorylation but was without effect on total EGFR or its phosphorylation, suggesting some cross-talk between EGF-stimulated activation of class I PI3K and MAPKs in MCF10A cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epidermal Growth FactorPhosphotransferases (Alcohol Group Acceptor)PhosphatidylinositolsPhosphatidylinositol PhosphatesHumansIsoenzymesCell LinePhosphatidylinositol 4,5-Diphosphate

Substanzen

Epidermal Growth Factor1-phosphatidylinositol-4-phosphate 5-kinasePhosphotransferases (Alcohol Group Acceptor)PhosphatidylinositolsIsoenzymesPhosphatidylinositol PhosphatesPhosphatidylinositol 4,5-Diphosphate

Autor:innen und Institutionen

  • Babraham Institute, Cambridge, United Kingdom.
  • Astra Zeneca, Cambridge, United Kingdom.
  • Cancer Research Horizons Therapeutic Innovation, Babraham Research Campus, Cambridge, United Kingdom.

ORCID-Profile: Iosif Alexandrou, Martin E Swarbrick

Förderung

  • Biotechnology and Biological Sciences Research Council

Zitieren

APA

Alexandrou, I., Flemington, V., Swarbrick, M. E., Cosulich, S., Hawkins, P. T., & Stephens, L. R. (2026). PIP5K isoforms and phosphoinositide molecular species in EGF-stimulated PIP3 synthesis: A multi-method approach using enzyme genetic suppression and chemical inhibition in MCF10A cells. PLOS One, 21(11), e0362260. https://doi.org/10.1371/journal.pone.0362260

Vancouver

Alexandrou I, Flemington V, Swarbrick ME, Cosulich S, Hawkins PT, Stephens LR. PIP5K isoforms and phosphoinositide molecular species in EGF-stimulated PIP3 synthesis: A multi-method approach using enzyme genetic suppression and chemical inhibition in MCF10A cells. PLOS One. 2026;21(11):e0362260. doi:10.1371/journal.pone.0362260

BibTeX
@article{Alexandrou2026,
  author = {Alexandrou, Iosif and Flemington, Vikki and Swarbrick, Martin E and Cosulich, Sabina and Hawkins, Phillip T and Stephens, Len R},
  title = {PIP5K isoforms and phosphoinositide molecular species in EGF-stimulated PIP3 synthesis: A multi-method approach using enzyme genetic suppression and chemical inhibition in MCF10A cells},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {11},
  pages = {e0362260},
  doi = {10.1371/journal.pone.0362260}
}
Kostenlos starten →